US Patent Issued to Fate Therapeutics on Sept. 16 for "Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs" (California Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,989, issued on Sept. 16, was assigned to Fate Therapeutics Inc. (San Diego).

"Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs" was invented by Bahram Valamehr (San Diego), Ramzey Abujarour (San Diego) and Peter Flynn (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides cell culture conditions for culturing stem cells, including feeder-free conditions for generating and culturing human induced pluripotent stem cells (iPSCs). More particularly, the invention provides a culture platform that allows long-term culture of pluripotent cells in a feeder-free environment; reprogramming of cells i...